MOBI — Mobia Medical Share Price
Last trade - 00:00- $276.65m
- $283.78m
- $32.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.54 | ||
| Price to Tang. Book | 9.54 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.63 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -122.21% | ||
| Return on Equity | -246.09% | ||
| Operating Margin | -144.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 15.64 | 32.04 | 55.03 | 78.72 | 104.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- March 5th, 2007
- Public Since
- May 8th, 2026
- No. of Employees
- 167
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 33,291,096
- Address
- 2802 Flintrock Trace, Suite 226, AUSTIN, 78738
- Web
- https://www.mobia.com
- Phone
- +1 2146003057
- Auditors
- PricewaterhouseCoopers LLP
Latest News for MOBI
Upcoming Events for MOBI
Q3 2026 Mobia Medical Inc Earnings Release
Q3 2026 Mobia Medical Inc Earnings Call
Q4 2026 Mobia Medical Inc Earnings Release
Similar to MOBI
10x Genomics
NASDAQ Global Select Market
Alamar Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
AngioDynamics
NASDAQ Global Select Market
FAQ
As of Today at 04:09 UTC, shares in Mobia Medical are trading at $8.31. This share price information is delayed by 15 minutes.
Shares in Mobia Medical last closed at $8.31 and the price had moved by over the past 365 days. In terms of relative price strength the Mobia Medical share price has matched the S&P500 Index by over the past year.
The overall consensus recommendation for Mobia Medical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMobia Medical does not currently pay a dividend.
Mobia Medical does not currently pay a dividend.
Mobia Medical does not currently pay a dividend.
To buy shares in Mobia Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $8.31, shares in Mobia Medical had a market capitalisation of $276.65m.
Here are the trading details for Mobia Medical:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: MOBI
Based on an overall assessment of its quality, value and momentum Mobia Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Mobia Medical is $18.00. That is 116.61% above the last closing price of $8.31.
Analysts covering Mobia Medical currently have a consensus Earnings Per Share (EPS) forecast of -$2.81 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mobia Medical. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $8.31, shares in Mobia Medical were trading -28.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mobia Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $8.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Mobia Medical's directors